This represents the first therapeutic dose where most people experience significant appetite suppression and weight loss
The analyses were based on complete-case on-treatment measurements ( N = 249) for histological parameters that showed a statistically significant effect of semaglutide
As patients are transitioning from their often cheaper compounded versions to FDA-approved versions of the GLP-1s, we should take extra care to help patients navigate cost and insurance hurdles such as prior authorizations
Potential side effects from unofficial reports reveal that BPC-157 may: speed up cancer growth in cancer patients dizziness flushing racing heart blood pressure changes mood swings Currently, all available animal studies do not report any potential side effects of toxicity of BPC -157
Huang J, Liu L, Chen C, et al
In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks